semaglutide/nad+ Semaglutide vs Tirzepatide: Compare Diabetes Medications Injectable Semaglutide Shows Early Promise

Protein fortification is not a new trend

North American Spine Society: Specialty society guideline focusing on spinal disorders and musculoskeletal care

Medical conditions associated with the metabolic syndrome such as type 2 diabetes, hypertension, obesity, and hyperlipidemia are all associated with NAFLD

Bottom line: New GLP-1 medicines may be only a few years away, but in the meantime, proven options like Ozempic and Wegovy already offer major health benefits

Researchers opting for the 8mg maintenance dose would reach it at week 16, and the 4mg dose after just 4 weeks on the escalation schedule

If you are ready to begin a personalized plan, complete the free assessment quiz and connect with a provider who can help tailor your schedule based on how your body is responding